To support growth in life sciences and innovation in Australia.

Wentworth Capital recognised that life sciences was a high growth sector in Australia. In response, we established the Area53 platform to support Australian talent on home soil.

Acquired Citiport warehouse and office complex in Melbourne's Fishermans Bend. Offering purpose-built labs and cold shell fitouts for startups through to industry leaders

Our team travelled to the US and UK to study world-class life sciences facilities, gaining valuable insights and best practices to inform the development of Area53.

Ashlie Hartigan joined as our Associate in Science and Innovation, heading up Area53, bringing experience from leading institutions in the UK, Europe and Australia.

Acquired 1,500 sqm of high-quality lab and office space at 37 Epping Road in Macquarie Park. Home to Teva Pharmaceuticals, a global leader in generic medicines and R&D.

Acquired 17 O'Riordan St, Alexandria. Home to Lifeblood’s Sydney Processing Centre, an essential service provider for Australian healthcare.

Acquired 5 - 11 Julius Ave and 14 Julius Ave, North Ryde. A flagship site of scientific research located in Australia's first science precinct - Macquarie Park Innovation District. Built by CSIRO to meet the ever-changing needs of research and tech innovation this is a campus that fosters collaboration and invention.